Kallyope Inc. Announces $66M Series B Financing to Advance Programs Targeting the Gut-Brain Axis

All existing backers including Lux Capital, The Column Group, and Polaris Partners joined by new investors Euclidean Capital and Two Sigma Ventures Progress in building a comprehensive map of gut-brain circuits and identification of therapeutic opportun... Biopharmaceuticals, Neurology, Venture Capital Kallyope, gut-brain axis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news